AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery
The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The …
All Posts
QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery
The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence …
Gandeeva Therapeutics and Moderna Join Forces to Explore AI-Enabled Cryo-EM Technology
Gandeeva Therapeutics, a precision medicine company specializing in designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and …
Portal Innovations Empowers Biotech Ventures in Chicago and Atlanta
Portal Innovations, headquartered in Chicago, is a biotech-focused venture capital company seeking to bolster the expansion of biotech startups in …
MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology
As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This …
AI Drug Discovery Financing Roundup: Unlearn.AI, Iktos, DenovAI, and More
The role of artificial intelligence (AI) in drug discovery is rapidly increasing, since it was shown to be able to …
Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery
Oxford Drug Design, a biotechnology company with core expertise in computer-aided drug design, has announced that it has been engaged …
The State of A.I. Drug Discovery and Its Future: Small Molecules, Vaccines, and Antibodies
Artificial intelligence (A.I.) and big data in a synergistic integration have led to promising results in new drug development by …
The Potential of Artificial Intelligence to Transform the European Life Sciences Landscape (with a Caveat)
The adoption of artificial intelligence (AI) in life sciences has been rapidly expanding across the globe, and the European Union …
Altasciences Boosts Life-Saving Drug Development with Proscia's Digital Pathology Platform
In a strategic move to improve the drug development process, Altasciences has partnered with Proscia, a leading provider of digital …
Proscia Enhances Preclinical R&D Platform: Streamlining Pathology Workflows for Faster Drug Safety Decisions
Proscia, a company specializing in digital and computational pathology solutions, recently announced updates to its preclinical research and development (R&D) …
AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries
As we delve deeper into the uncharted territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) …